U.S. Markets open in 2 hrs 26 mins

Tetra Bio-Pharma Inc. (TBPMF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1350-0.0050 (-3.57%)
At close: 12:38PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1400
Open0.1260
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1260 - 0.1375
52 Week Range0.0940 - 0.6045
Volume42,738
Avg. Volume117,374
Market Cap39.004M
Beta (5Y Monthly)1.69
PE Ratio (TTM)N/A
EPS (TTM)-0.0290
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Tetra Bio-Pharma Provides Update on Recent Milestones
    ACCESSWIRE

    Tetra Bio-Pharma Provides Update on Recent Milestones

    * Plenitude Trial initiated * Tetra completes clinical study assessing the metabolism profile of cannabinoids in humans * Achieved development of ARDS-003 sterile injectable nano-emulsion for human useOTTAWA, ON / ACCESSWIRE / November 16, 2020 / Tetra Bio-Pharma Inc.

  • Tetra Bio-Pharma Provides Update on Market Potential of ARDS-003
    ACCESSWIRE

    Tetra Bio-Pharma Provides Update on Market Potential of ARDS-003

    * Initial Drug Indication Targets COVID-19 Related Survival Benefits * Cost-Saving Including When Used With a Remdesivir™ Standard of Care * Expanded Post-Survival Indications (Reduce the Risk of Fibrosis and Multi-Organ Dysfunctions) * Tetra Estimates Potential Revenues From Royalties on Net Sales, Milestone and Upfront Payments of Over $500 Million USD by 2026OTTAWA, ON / ACCESSWIRE / November 4, 2020 / Tetra Bio-Pharma Inc.

  • CNW Group

    Tetra Bio-Pharma Inc. Acquires Common Shares of Mondias Natural Products Inc.

    OTTAWA, ON, Nov. 2, 2020 /CNW Telbec/ - Tetra Bio-Pharma Inc.